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Abstract Recent genome-wide studies conducted in
European Whites have identified novel susceptibility genes
for childhood acute lymphoblastic leukemia (ALL). We
sought to examine whether these loci are susceptibility
genes among Hispanics, whose reported incidence of
childhood ALL is the highest of all ethnic groups in
California, and whether their effects differ between His-
panics and non-Hispanic Whites (NHWs). We genotyped
13 variants in these genes among 706 Hispanic (300 cases,
406 controls) and 594 NHW (225 cases, 369 controls)
participants in a matched population-based case–control
study in California. We found significant associations for
the five studied ARID5B variants in both Hispanics (p val-
ues of 1.0 9 10-9 to 0.004) and NHWs (p values of
2.2 9 10-6 to 0.018). Risk estimates were in the same
direction in both groups (ORs of 1.53–1.99 and 1.37–1.84,
respectively) and strengthened when restricted to B-cell
precursor high-hyperdiploid ALL ([50 chromosomes; ORs
of 2.21–3.22 and 1.67–2.71, respectively). Similar results
were observed for the single CEBPE variant. Hispanics and
NHWs exhibited different susceptibility loci at CDKN2A.
Although IKZF1 loci showed significant susceptibility
effects among NHWs (p \ 1 9 10-5), their effects among
Hispanics were in the same direction but nonsignificant,
despite similar minor allele frequencies. Future studies
should examine whether the observed effects vary by
environmental, immunological, or lifestyle factors.
Keywords Childhood cancer  Leukemia  Genetic
susceptibility
Introduction
Acute lymphoblastic leukemia (ALL) is the most common
cancer among children under the age of 15 in Western coun-
tries, and its etiology is poorly understood. In 2009, two gen-
ome-wide genetic susceptibility studies based on European
White populations identified novel loci for the risk of childhood
ALL in ARID5B (10q21.2), IKZF1 (7p12.2), and CEBPE
(14q11.2) [1, 2]. In both studies, the loci in ARID5B were found
to have particularly strong effects for the B-cell precursor
hyperdiploid subtype of childhood ALL [1, 2]. These associa-
tions have been confirmed in additional European White pop-
ulations [3–5]. Variation in ARID5B (rs10821936) has been
associated with ALL risk in African American, Thai, and
Hispanic populations [6–8]. Furthermore, a locus in CDKN2A
(9p21.3) that did not reach genome-wide significance in one of
the original genome-wide studies [2] was found to be signifi-
cantly associated with the risk of childhood ALL using a larger
European White validation set [9].
Most genome-wide studies on childhood ALL con-
ducted to date have been limited to White populations.
Understanding the effects of these variants in different
populations is crucial because reported incidence rates of
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childhood ALL among California’s population who self-
identify as Hispanic ethnicity (‘‘Hispanics’’) are higher
than those for any other racial/ethnic subgroup in Califor-
nia, including non-Hispanic Whites [10]. Reasons for these
higher rates are unclear. In addition, Hispanics tend to have
a worse prognosis versus non-Hispanic Whites, and
ARID5B has been linked to poorer outcomes [8]. Hispanics
are a recently genetically admixed group [11], and we have
previously observed differences in haplotype structure
between Hispanics and non-Hispanics [12], suggesting that
they may not share the same susceptibility loci. Therefore,
it is possible that the higher observed ALL incidence rates
among Hispanics may be related to differences in genetic
susceptibility loci, including those in ARID5B, IKZF1,
CEBPE, and CDKN2A.
The current study based in California examines the role
of these loci in childhood ALL risk among Hispanics and
ascertains whether the effects of these loci differ between
self-reported Hispanics and non-Hispanic Whites.
Materials and methods
Study subjects
The study was conducted among participants in the
Northern California Childhood Leukemia Study (NCCLS),
whose recruitment and enrollment procedures have been
described in detail previously [13]. Briefly, this population-
based case–control study started in 1995 and recruited
subjects from 35 counties in Northern and Central Cali-
fornia. Case subjects newly diagnosed with leukemia were
recruited from nine hospitals in the catchment area, usually
within 72 h of diagnosis. Comparison with the California
Cancer Registry (1997–2003) showed that the NCCLS case
ascertainment protocol has captured *95 % of children
diagnosed with leukemia in the participating study hospi-
tals. When considering both participating and nonpartici-
pating hospitals within the study region, cases ascertained
through the NCCLS represent *76 % of all diagnosed
cases. Birth certificate information obtained from the
Office of Vital Records at the California Department of
Public Health (CDPH) was used to select one to two
controls for each case, matching on date of birth, sex,
Hispanic ethnicity (at least one parent self-reporting His-
panic ethnicity), and maternal race (White, Black, Asian/
Pacific Islander, Native American, and Other/Mixed).
The child’s own race/ethnicity was defined according to
that of both parents. For example, a child was considered
non-Hispanic White if both parents reported being non-
Hispanic ethnicity and White race. Children of parents
reporting different races were considered to be of Mixed/
Other race. Any child with a parent reporting Hispanic
ethnicity was considered Hispanic, regardless of parental
race. The eligibility criteria for cases and controls were as
follows: (a) residency in the study area, (b) being younger
than 15 years at case diagnosis (reference date for the mat-
ched controls), (c) having at least one English- or Spanish-
speaking parent or guardian, and (d) having not been previ-
ously diagnosed with cancer. Interview rates among eligible
cases and controls were 80 and 84 %, respectively, and did
not vary markedly by Hispanic ethnicity.
The current analysis includes Hispanic and non-His-
panic White ALL case and control subjects recruited
between 1995 and 2008 who had available DNA speci-
mens. These two racial/ethnic groups together comprise
*85 % of enrolled subjects. A child was considered His-
panic if either parent self-reported Hispanic ethnicity,
regardless of self-reported parental race. Non-Hispanic
White subjects were those whose parents both self-reported
as being of non-Hispanic ethnicity and White race. Other
race/ethnicity groups (non-Hispanic Blacks, non-Hispanic
Asians and Pacific Islanders, non-Hispanic Native Ameri-
cans, and non-Hispanic Mixed) were not considered due to
small number of subjects in each. Children less than 1 year
of age at diagnosis/reference date were excluded due to
growing evidence that these leukemias may be etiologi-
cally distinct compared to leukemia diagnosed at later ages
[14]. Based on the previous reports of stronger effects for
B-cell precursor (BCP) ALL and specifically BCP high-
hyperdiploid ALL ([50 chromosomes), we also considered
these two subgroups in our analyses. The cytogenetic
classification methods used in this analysis have been
described in detail elsewhere [15]. Briefly, pretreatment
diagnostic karyotype and fluorescence in situ hybridization
(FISH) data were abstracted from leukemia patient records
shortly after diagnosis. Additional FISH analyses were
conducted at the University of California, Berkeley, to
identify hyperdiploidy when not done at hospitals.
This study was reviewed and approved by institutional
review committees at the University of California Berkeley,
the CDPH, and the participating hospitals. Written informed
consent was obtained from all parent respondents.
DNA processing and genotyping
DNA specimens from buccal cytobrushes collected by
trained interviewers from 95 % of participating children
(cases and controls) were processed within 48 h of collection
by heating in the presence of 0.5 N NaOH. DNA thus iso-
lated was later repurified either manually using Gentra
Puregene reagents (QIAGEN, USA, Valencia, CA) or an
automated organic DNA extraction protocol (AutoGen,
Holliston, MA). Whole-genome amplification (WGA) of
buccal cell DNA was performed using GenomePlex reagents
(Rubicon Genomics, Ann Arbor, MI) according to the
1790 Cancer Causes Control (2013) 24:1789–1795
123
manufacturer’s protocol. WGA products were cleaned with a
Montage PCR9 filter plate (Millipore, Billerica, MA). When
buccal cytobrush DNA was inadequate or not available
(26.6 % of subjects), DNA was isolated from dried blood-
spots collected at birth and archived by the Genetic Diseases
Screening Program of the CDPH. After extraction using the
QIAamp DNA Mini Kit (QIAGEN, USA, Valencia, CA),
these DNA samples were whole-genome amplified using
REPLI-g reagents (QIAGEN, USA, Valencia, CA). We
previously genotyped DNA specimens from both buccal
cells and DBS for nine subjects; genotype concordance
between paired samples was 98.9 % [16]. Regardless of
source, DNA specimens were quantified using human-spe-
cific Alu-PCR to confirm a minimum level of amplifiable
human DNA [17] and randomized prior to genotyping.
We performed Sequenom iPlex genotyping of 11 of 13
previously identified SNPs [1, 2, 9] as follows: ARID5B
(rs10994982, rs10740055, rs7073837, rs7089424, and
rs10821936), IKZF1 (rs11978267), CEBPE (rs2239633), and
CDKN2A (rs3731217, rs3218018, rs2811712, and rs3731239).
The average SNP call rate was 96.7 %. Genotypes for duplicate
DNA specimens (n = 154 per SNP) showed 100 % concor-
dance. The two remaining SNPs, one in IKZF1 (rs4132601) and
the other in CDKN2A (rs4074785), were typed using TaqMan
assays. The average SNP call rate was 98.2 %. Genotypes for
duplicate DNA specimens (n = 146 per SNP) showed 100 %
concordance. All SNPs were tested for deviation from Hardy–
Weinberg equilibrium using SAS version 9.2 software, strati-
fied by ethnicity. SNPs were excluded from statistical analyses
if they had a call rate of\90 %, had a minor allele frequency
\5 %, or failed Hardy–Weinberg equilibrium (p\ 0.01) in
both Hispanic and non-Hispanic White controls.
Statistical methods
Logistic regression was used to estimate the association of
individual SNPs with the risk of childhood ALL. Although
individual matching was used in the study design, because
not all cases had a matched control by the time genotyping
was conducted, we used unconditional logistic regression
adjusted for the matching factors (age at diagnosis and sex, as
well as child’s race for Hispanics only) to ensure data for all
available subjects were included. Analyses were conducted
for total ALL, for BCP ALL, and for BCP high-hyperdiploid
ALL, stratified by ethnicity (non-Hispanic Whites versus
Hispanics). We used log-additive inheritance models to test
for trend in association with copies of the minor allele. For
each SNP, the referent allele was set to match that reported
previously [1, 2, 9], even in instances where this allele was
less common in our study populations. Results are reported
separately for Hispanics and non-Hispanic Whites. p val-
ues \ 0.05 were considered statistically significant.
Results
A total of 706 Hispanics (300 cases and 406 controls) and
594 non-Hispanic Whites (225 cases and 369 controls)
were included in this study (Table 1). As expected, there
was some racial variation among Hispanics, with a sizable
Table 1 Characteristics of study population
Hispanic Non-Hispanic Whites
Cases Controls Cases Controls
Total 300 406 225 369
Age of child Mean SD Mean SD Mean SD Mean SD
Years 5.6 3.6 5.5 3.6 5.6 3.4 5.7 3.8
Sex of child N % N % N % N %
Male 156 52.0 214 52.7 125 55.6 221 59.9
Female 144 48.0 192 47.3 100 44.4 148 40.1
Race of child
White 114 38.0 116 28.6 225 100 369 100
African American 2 0.7 0 0.0 – – – –
Native American 6 2.0 11 2.7 – – – –
Asian/Pacific Islander 0 0.0 3 0.7 – – – –
Mixed/other 178 59.3 276 68.0 – – – –
Cytogenetic grouping (cases only)
Total B-cell precursor ALL 279 93.0 – – 202 89.8 – –
B-cell precursor high-hyperdiploid ALL 85 28.3 – – 62 27.6 – –
Cancer Causes Control (2013) 24:1789–1795 1791
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proportion (59–68 %) reporting ‘‘Mixed/Other’’ race. The
frequency of BCP ALL was 93.0 and 89.8 % among the
Hispanic and non-Hispanic White cases, respectively,
while the prevalence of BCP high-hyperdiploid ALL ([50
chromosomes) was 28.3 and 27.6 %, respectively.
Association tests and ORs for the defined minor alleles of
all 13 SNPs are shown in Table 2. Among non-Hispanic
Whites, we observed significant associations with the risk of
total ALL with all five ARID5B variants (p values from 0.018
to 2.2 9 10-6). Risk estimates for the ARID5B variants
increased when restricted to BCP high-hyperdiploid ALL; this
effect was particularly marked for rs7073837, rs7089424, and
rs10821936. The CEBPE variant rs2239633 was also signif-
icantly associated with total ALL risk among non-Hispanic
Whites (p = 0.005), and the effect size increased when
restricted to BCP ALL, regardless of hyperdiploidy. The two
minor allele variants in IKZF1 also showed significant asso-
ciations with total ALL (p value = 7.8 9 10-6 and 8.4 9
10-6, respectively) among non-Hispanic Whites, and their
effects were similar across disease subgroups. For CDKN2A,
none of the five studied variants was significantly associated
with ALL among non-Hispanic Whites. However, one
CDKN2A SNP, rs3731217, showed a suggestive association
with total ALL [OR 0.71 (0.49–1.03)] that gained strength and
reached significance when restricted first to BCP ALL [OR
0.66 (0.44–0.99)] and then to BCP high-hyperdiploid ALL
[OR 0.46 (0.22–0.95)].
The effects of the 13 variants with childhood ALL risk
among Hispanics are also shown in Table 2. Similar to the
effects observed among non-Hispanic Whites, all five
ARID5B SNPs were significantly associated with the risk of
total ALL (p values from 0.0004 to 1 9 10-9). As before,
effect sizes were notably stronger when restricted to BCP
high-hyperdiploid ALL, but among Hispanics, this
strengthening was evident for all five SNPs (OR for BCP
high-hyperdiploid ALL is 1.5 times that of total ALL). The
minor alleles of the five ARID5B SNPs were more com-
mon, and risk estimates were somewhat stronger among
Hispanics than among non-Hispanic Whites. Among His-
panics, the single SNP in CEBPE was suggestively asso-
ciated with total ALL (p = 0.0671) and showed the same
strengthening of the effect for BCP high-hyperdiploid ALL
[OR 1.81 (1.24–2.66)] as was observed among non-His-
panic Whites, but not total BCP ALL. For the IKZF1 SNPs,
although the risk estimates among Hispanics were the same
direction as those among the non-Hispanic Whites, they
were of lower magnitude (ORs 1.20–1.22 vs. 1.80–1.81
among non-Hispanic Whites), and the p values were not
significant, and these effects did not differ by disease
subgroup. Finally, two of the five SNPs in CDKN2A,
rs3218018 and rs2811712, were significantly associated
with childhood ALL among Hispanics (p = 0.0145 and
0.0315), and this effect was strongest for BCP high-
hyperdiploid ALL. These associations were not observed
among non-Hispanic Whites.
Discussion
In this study we examined the associations of previously
identified childhood ALL risk loci in both non-Hispanic
Whites and Hispanics, whose recent admixture and ele-
vated incidence rates of childhood ALL warrant special
attention in studies of genetic susceptibility. To our
knowledge, this is the first study to examine the role of
these variants in a Hispanic population. Our results indicate
that while some previously identified susceptibility loci,
including those in ARID5B and CEBPE, are consistent
across the two studied populations, others, including those
in IKZF1 and CDKN2A, may have different effects.
The genes studied here were identified through previous
genome-wide interrogation and replication in European
White populations. Given the suspected roles of ARID5B,
CEBPE, and IKZF1 in B-cell development, the biological
plausibility of their involvement in ALL etiology is strong.
We expected the non-Hispanic White population in our
study to closely resemble the European Whites reported in
the previous studies [1–4]. In this group, we found results for
SNPs in ARID5B, CEBPE, and IKZF1 that were remarkably
similar to those from the previous studies, including both the
direction and magnitude of previously reported effects.
The consistency of results from our non-Hispanic White
population with those from European White populations,
taken together with the consistency of observed effects of loci
in ARID5B, and to a lesser extent CEBPE, between Hispanic
and non-Hispanic White populations in our study, provides
compelling support that these loci are indeed involved in risk
of childhood ALL, particularly BCP high-hyperdiploid ALL.
The higher observed risk estimates for these loci in Hispanics
versus non-Hispanic Whites are intriguing. If real, they may
be due to the differences in either the genetic structure in the
region of these variants or the prevalence of exposures
(including environmental/lifestyle exposures) that modify the
risks associated with these variants.
While we did not observe statistically significant asso-
ciations of the two studied IKZF1 SNPs with childhood
ALL susceptibility among Hispanics, the direction of
observed effects for the specified allele was similar to those
observed among non-Hispanics. In addition, the p value for
rs4132601 among Hispanics was borderline significant
(p = 0.08), suggesting that, with a larger sample and
therefore greater statistical power, the association could be
significant. It is possible that the IKZF1 associations
observed among our non-Hispanic Whites and among the
European White populations in the previous studies [1–4]
are indirect, due to linkage disequilibrium with functional
1792 Cancer Causes Control (2013) 24:1789–1795
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loci elsewhere. In this case, effects for the studied IKZF1
loci, and indeed other loci whose observed susceptibility
effects differ between populations, might be obscured by
differences in linkage patterns due to the recent admixture
of the Hispanic population.
Separately, the effects of CDKN2A, a cell cycle control
gene known to be a tumor suppressor, were not strong
enough to reach genome-wide significance in the previous
genome-wide studies of European Whites and therefore
required a larger independent replication sample for final
identification [6]. Among the non-Hispanic Whites in our
study, we observed suggestive associations of the same
CDKN2A variant previously reported among European
Whites [6]. However, among Hispanics, two different
CDKN2A loci were significantly associated with childhood
ALL. As noted above, this observed difference between
Hispanics and non-Hispanic Whites may be due to either
small effects of the CDKN2A loci, which would require
larger sample sizes for consistent observation, or genetic
heterogeneity surrounding the CDKN2A locus. In sum-
mary, although CDKN2A shows some effects, further
studies are needed to clarify whether or not CDKN2A
variants are indeed childhood ALL susceptibility loci.
In this study, our goal was to attempt to replicate the pre-
vious findings and determine the effect sizes of previously
identified susceptibility loci in both a replication population
(non-Hispanic Whites) and a different, higher-risk population
(Hispanics). Accordingly, we did not impose control for
multiple testing—all reported p values are nominal. While
application of approaches such as the false discovery rate [18]
would undoubtedly render some of the findings reported here
nonsignificant, several loci would likely persist, notably those
in ARID5B, due to their low nominal p values.
In our race- and ethnicity-matched study population, we
have previously calculated genetic ancestry on the basis of a
panel of 96 ancestry informative markers selected to dis-
tinguish continental origin among California Hispanics [19].
As part of this work, we found that adjustment for the
child’s race and Hispanic ethnicity, as reported by the
mother, yields individual SNP risk estimates not substan-
tially different from those derived from models adjusted for
estimated genetic ancestry [20]. We observed similar mini-
mal changes in SNP risk estimates after further adjustment
for genetic ancestry (data not shown); accordingly, we report
the effects of the most parsimonious model, adjusted only
for race (a matching factor). Based on these results, it is
unlikely that the observed risk estimates, or the observed
susceptibility differences across populations, are due solely
to latent population stratification or cryptic relatedness.
In conclusion, we found that previously identified
childhood ALL susceptibility loci in ARID5B and CEBPE
show consistent risk effects across both Hispanic and
non-Hispanic White populations, providing compelling
supportive evidence for susceptibility at these loci. In
contrast, IKZF1 and CDKN2A variants displayed varying
susceptibility loci between populations. Future studies with
larger sample sizes should examine the effects of these
variants in other subgroups of ALL and examine whether
these effects vary by other environmental (immunological)
factors/lifestyle factors.
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